Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.60p
   
  • Change Today:
      0.25p
  • 52 Week High: 11.50
  • 52 Week Low: 6.55
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 1,368,085
  • Market Cap: £53.00m

Poolbeg Pharma Overview

Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the “one-stop shop” for Big Pharma seeking mid-stage products to license or acquire.

Key Personnel

CEO: Jeremy Skillington
CFO: Ian O’Connel
Executive Chairman: Cathal Friel
Independent Non-Executive Director: Brendan Buckley
Independent Non-Executive Director: Edward Gibson
Independent Non-Executive Director: Luke O’Neill
Non-Executive Dir:

Contact Details

Address: Queen Mary Bioenterprises Innovation Centre, 42 New Road, London, United Kingdom, E1 2AX
Phone: +44 (0)20 7183 1499
Website: http://www.poolbegpharma.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BKPG7Z60

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 10.60p
Change Today 0.25p
% Change 2.42 %
52 Week High 11.50
52 Week Low 6.55
Volume 1,368,085
Shares Issued 500.00m
Market Cap £53.00m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.29% below the market average61.29% below the market average61.29% below the market average61.29% below the market average61.29% below the market average
47.17% below the sector average47.17% below the sector average47.17% below the sector average47.17% below the sector average47.17% below the sector average
Price Trend
93.93% above the market average93.93% above the market average93.93% above the market average93.93% above the market average93.93% above the market average
96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
16:24 130,000 @ 10.50p
16:21 40,682 @ 10.50p
15:56 1,968 @ 10.50p
15:54 30,000 @ 10.60p
15:36 234 @ 10.67p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page